You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.9% | 4.4% |
| Div Cover | n/a | 2.6 |
| Op Mrgn | n/a | 27.1% |
| ROCE | n/a |
| Latest | Forecast | |
|---|---|---|
| P/E | 39.6 | 0.0 |
| PEG | -0.5 | 11.7 |
| Price / Revenue | 9.6 | 1.8 |
| Price / Book value | 5.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 3.4% | 0.2% |
| PBT | 7.7% | n/a |
| EPS | 11.0% | 0.2% |
| DPS | -4.5% | -1.7% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 33,754.00 | 6,221.00 | 123.90p | 17.9 | 4.8 | 4% | 80.00p | 3.6% |
| 2020-12-31 | 34,099.00 | 6,968.00 | 115.90p | 14.5 | -2.2 | -6% | 80.00p | 4.8% |
| 2021-12-31 | 24,696.00 | 3,599.00 | 90.56p | 22.2 | -1.0 | -22% | 80.00p | 4.0% |
| 2022-12-31 | 29,324.00 | 5,628.00 | 139.70p | 10.3 | 0.2 | 54% | 44.00p | 3.1% |
| 2023-12-31 | 30,328.00 | 6,064.00 | 155.10p | 9.4 | 2.8 | 3% | 42.00p | 2.9% |
| London close: Stocks end turbulent week in the red Sharecast News | 15 Nov |
|---|---|
| GSK's Blenrep shows strong survival benefit in myeloma study Sharecast News | 14 Nov |
| London close: Stocks mixed as Chancellor unveils tax hikes Sharecast News | 30 Oct |
| GSK announces overall survival results for Blenrep | 14-Nov-24 07:02 |
|---|---|
| Block listing Interim Review | 13-Nov-24 15:00 |
| Director/PDMR Shareholding | 12-Nov-24 15:30 |
| GSK publishes provisional 2025 dividend dates | 11-Nov-24 15:01 |
| Total Voting Rights | 01-Nov-24 15:00 |